Pinaverium bromide is an L-type calcium channel blocker that selectively targets the gastrointestinal tract. It is effective in relieving pain, diarrhea, and intestinal discomfort, offering therapeutic benefits without significant adverse effects in patients with Irritable Bowel Syndrome (IBS). It is intended for research use only.
- Selectively blocks L-type calcium channels
- Relieves pain, diarrhea, and intestinal discomfort
- Provides therapeutic efficacy for Irritable Bowel Syndrome (IBS)
- Exhibits good safety profile with no significant adverse effects
- Inhibits neutrophil migration and ROS production
- Reduces expression of inflammatory cytokines (IL-1β, IL-6, TNF-α)
- Increases survival rate and reduces lung and liver injury in LPS-induced animal models